A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Preoperative thyroid-stimulating hormone associated risk of differentiated thyroid cancer in patients with thyroid nodules
Cellular and Molecular Biology
In an assessment of risk for differentiated thyroid cancer (DTC) in individuals with human papillary thyroid cancer (PTC) and thyroid nodules a cohort prospective study was undertaken to establish the significance of preoperative thyroid-stimulating hormone (TSH) levels. Confirmed histologically PTC cases in one tertiary care center, and matched healthy individuals were tested for TSH, T3, T4 and T4 free total. The ORs and 95% confidence intervals have been calculated using conditional logisticdoi:10.14715/cmb/2021.67.3.11 pmid:34933729 fatcat:hbqlzla27feoriqaxa2dv7ad24